Damian Wang

Damian joined Sonoma Bio in 2021 with a diversity of experience in program and alliance management, strategic operations, and organizational development.

He was most recently at Astellas Gene Therapies (formerly Audentes Therapeutics) managing their gene therapy research portfolio and providing operational expertise to their Research and Tech Ops organizations. Prior to Astellas, Damian worked at 23andMe leading global cross-functional projects and partnerships in research, health product, and clinical trial solutions.

Damian earned his PhD in Genetic, Molecular, and Cellular Biology from the Keck School of Medicine of the University of Southern California and his BS in Biochemistry and Cell Biology from the University of California San Diego.